10 min read

AI in drug discovery: revolutionizing the future of medicine

AI & ML

Healthcare

Artificial intelligence (AI) isn’t just helping us find new drugs; it’s changing how we think about innovation. Smarter drugs, tailored to your DNA, with fewer side effects, isn’t science fiction — it’s what AI is doing now. Take a look at how AI is changing the way we think about drugs, one algorithm at a time.

How AI is changing approaches to drug discovery

AI is transforming the pharmaceutical industry, and one of the most significant areas of impact is in the drug discovery process. Using advanced machine learning algorithms, such as transformer models and graph neural networks, and vast amounts of data, AI is accelerating the discovery of new treatments and improving the efficiency of the entire development process.

Data-driven target identification

Faster pre-clinical research

AI-driven drug design

Predictive modeling and simulation

Optimized clinical trials with AI

Personalized medicine and real-world evidence

Data-driven target identification

Before designing a drug, we need to pinpoint the therapeutic target – a specific enzyme, a mutated gene, or a critical signaling pathway. Through analysis of large-scale biological data, including genomic and transcriptomic information from next-generation sequencing (NGS), AI helps identify the best therapeutic opportunities, uncover complex patterns and connections that traditional methods may miss. This leads to the discovery of new targets and innovative treatments.

Faster pre-clinical research

AI optimizes pre-clinical research, mining data from in vitro and in vivo studies to predict compound efficacy and toxicity. This method helps researchers make smart choices about which compounds to pursue and thus save both time and resources. Furthermore, AI can optimize experimental design in pre-clinic selection of drug candidates for further development.

AI-driven drug design

AI is changing drug design with the generation of novel molecular structures optimized for efficacy and safety. AI algorithms identify promising candidates and explore chemical space beyond the limitations of traditional methods by analyzing massive datasets of existing compounds and their target interactions. This accelerates the discovery of innovative treatments with the potential to address unmet medical needs.

Predictive modeling and simulation

AI-powered predictive modeling and simulation further refines drug design by mimicking the behavior of complex biological systems. This in silico approach predicts drug performance at various stages, from absorption and distribution to metabolism and excretion: this way, the researchers can easily identify drug candidates for desired properties prior to costly experimental testing. This significantly improves the chances of clinical success.

Optimized clinical trials with AI

AI is playing an increasingly important role in clinical trials. It's used to analyze data from previous trials, identify patterns, and predict potential issues. This helps researchers design better trials, find the right patients, and increase the chances of a successful outcome while reducing costs and timelines. AI can also help them easily find and recruit patients for clinical trials. It can match patients to trials based on their specific characteristics and the trial criteria.

Personalized medicine and real-world evidence

The advancement of personalized medicine is supported by AI's ability to analyze large amounts of patient genomic data and medical history to identify individual biomarkers and develop targeted therapies. In addition, AI is analyzing real-world evidence and post-marketing surveillance data to identify potential safety issues and improve treatment outcomes in real-world settings.

Data-driven target identification

Faster pre-clinical research

AI-driven drug design

Predictive modeling and simulation

Optimized clinical trials with AI

Personalized medicine and real-world evidence

AI-driven services Innowise offers for drug discovery

Multiomics data analysis

Clinical data analysis

Scientific research data analysis

De novo drug design

ML + molecular dynamics

ML + molecular docking

Show all

Improve your AI-driven drug discovery with Innowise.

Our AI-driven services help you speed up your pipelines and get more accurate results.

Key benefits of AI in drug discovery and development

AI is a total change-maker in the pharmaceutical industry: it offers lots of benefits that make the drug discovery and development process smoother and more efficient.

Reduced development time and costs

More effective drugs

Improved clinical trial design

Greater predictive capabilities

Drug repurposing opportunities

Personalized medicine

Upgraded drug screening

Optimized drug formulation

Improved patient recruitment

Reduced development time and costs

Thanks to the rapid analysis of vast datasets, ML algorithms expedite every stage, from target identification and lead optimization to clinical trial design and drug repurposing. Compared to traditional methods, this accelerated pace significantly shortens development timelines and reduces costs.

More effective drugs

Correctly trained AI models are able to predict critical properties like target binding affinity, pharmacokinetic/pharmacodynamic profiles, and ADMET properties — and therefore help researchers design drugs with enhanced efficacy. This AI-driven approach optimizes drug candidates for improved target engagement, reduced toxicity, and ultimately, better patient outcomes.

Improved clinical trial design

AI models also help optimize clinical trial design by identifying ideal patient cohorts through predictive biomarkers and refining trial protocols for efficiency. This targeted approach increases the probability of successful trial outcomes and accelerates the delivery of life-changing medications to patients.

Greater predictive сapabilities

AI significantly increases the predictive power of drug discovery and helps researchers to forecast drug behavior, efficacy, and safety profiles. Using a variety of techniques, AI identifies promising candidates and potential liabilities early and accelerates development timelines.

Drug repurposing opportunities

AI algorithms analyze large data sets to identify new therapeutic applications for existing drugs. This drug repurposing strategy accelerates the development timeline because these drugs already have established safety profiles and clinical data, which decreases the need for extensive and costly de novo trials.

Personalized medicine

AI analyzes patient-specific data, including genetic and molecular profiles, to tailor treatments for optimal efficacy. For example, AI can predict an individual's response to a specific chemotherapy regimen based on their tumor's genetic makeup so that oncologists can select the most effective treatment while minimizing adverse reactions. This personalized approach maximizes the benefit of an individual patient.

Upgraded drug screening

AI automates high-throughput screening of vast compound libraries to identify promising drug candidates with greater efficiency than traditional methods. Through analysis of molecular structures and predicting their interactions with target proteins, AI can prioritize compounds with the highest likelihood of success, which significantly reduces the time and cost associated with early stages of drug discovery.

Optimized drug formulation

AI algorithms analyze the interplay of ingredients and their impact on stability, solubility, and bioavailability and predict optimal drug formulations. For instance, AI can model how different excipients affect a drug's dissolution rate and absorption in the gastrointestinal tract, which leads to improved drug efficacy, easier administration (e.g., oral instead of intravenous), and better patient compliance.

Improved patient recruitment

AI-powered analytics identifies ideal candidates for clinical trials based on a comprehensive analysis of patient data, including medical history, demographics, and genetic information. It identifies patients most likely to respond positively to a treatment. This targeted recruitment strategy improves trial efficiency, increases success rates, and ultimately accelerates the delivery of new therapies to patients.

Reduced development time and costs

More effective drugs

Improved clinical trial design

Greater predictive сapabilities

Drug repurposing opportunities

Personalized medicine

Upgraded drug screening

Optimized drug formulation

Improved patient recruitment

Examples of successful implementation of AI in drug discovery

This Hong Kong-based company uses AI for target discovery, drug design and clinical trial prediction. A notable achievement is their development of a drug candidate for idiopathic pulmonary fibrosis (IPF) that has entered Phase II clinical trials. This demonstrates a tangible result of their AI-driven drug discovery platform, which is moving beyond theoretical potential to clinical investigation.

The San Francisco-based company uses deep convolutional neural networks for structure-based drug design. Their AtomNet platform has been used to identify potential drug candidates for several diseases, including Ebola and multiple sclerosis. Their collaborations with pharmaceutical companies such as Eli Lilly and Bayer show the practical application of their technology in real-world drug discovery.

Known for their expertise in medicinal chemistry and machine learning, PostEra’s Manifold platform combines machine learning, retrosynthetic analysis, and cloud-based chemical synthesis. Their partnership with Pfizer, initially focused on COVID-19 antivirals, has expanded to other therapeutic areas. Their Open Synthesis initiative underscores their dedication to open source research and collaboration in drug discovery.

Real-life Innowise case studies of AI in drug discovery

Automating molecular property prediction in drug discovery

We developed a machine learning model to predict aqueous solubility for novel small molecule inhibitors targeting protein X. Using experimentally determined solubility data, we trained a custom ML pipeline leveraging molecular descriptors. The model achieved an R-squared of 0.70 on external validation, making it a valuable tool for screening virtual libraries and prioritizing compounds for synthesis.

Enhancing PBPK modeling with machine learning

We improved hepatic clearance predictions in a GastroPlus PBPK model using a hybrid machine learning approach. Combining LightGBM and D-MPNN graph neural networks, our model achieved an R-squared of 0.82 in cross-validation. The integration reduced average fold error from 2.5 to 2.0 compared to traditional in vitro scaling methods, enabling more reliable drug exposure predictions.

Social media monitoring for pharmacovigilance

Before designing a drug, we need to pinpoint the therapeutic target – whether it's a specific enzyme, a mutated gene, or a critical signaling pathway. Through analysis of large-scale biological data, including genomic and transcriptomic information from next-generation sequencing (NGS), AI helps identify the best therapeutic targeting opportunities. Advanced machine learning algorithms, such as graph neural networks and transfer learning,

FAQ

Can AI take the place of traditional methods in drug development?

AI isn’t a replacement for traditional methods in drug development. It’s a great tool to help speed things up and make them more efficient. While AI algorithms can analyze huge amounts of data, predict molecular properties, and identify potential drug candidates more efficiently than traditional approaches, it’s still important to test them out in real life.

How does Innowise make sure that AI projects comply with the relevant regulations?

Innowise’s AI projects are built to comply with all relevant regulatory standards (FDA, EMA, ICH, GDPR, HIPAA). We have rigorous data governance, validated and documented models, and a commitment to explainable AI. We make sure that the data we use is of good quality, secure, and transparent throughout the development process. This thorough process helps us avoid potential risks and guarantee reliable results for our clients.

What expertise do Innowise’s AI developers bring to drug discovery?

Proficient in machine learning (deep learning, reinforcement learning, classical techniques), cheminformatics, bioinformatics, and drug development processes, Innowise leverages industry-standard tools and technologies to create impactful AI solutions for drug discovery.

How can I hire AI developers from Innowise for my project?

You can hire AI developers from Innowise by contacting our team through our website. We offer flexible engagement models, including project-based contracts and dedicated teams, to best suit your project needs and budget and assemble a team of AI developers with the right expertise to deliver successful outcomes.